Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Doctor Killed in Double Stabbing; Thyroid Pill Recall Upgraded; HHS Nominee Advances

Health news and commentary gathered by MedPage Today staff

FDA Approves Efsitora Weekly Insulin for Type 2 Diabetes

— Approval marks the second once-weekly basal insulin for this population

Short Steroid Bursts Tied to Serious Adverse Events in Diabetes

— Analysis found increased pneumonia, heart failure, and bleeding risks

FDA Warns Pharmacy About Illegal GLP-1 Compounding

Agency's letter flagged issues with copycat manufacturing and sterility

2 Hot Dogs or 1 Large Cookie? A Study of Risks by Amount of Ultraprocessed Food

— Mounting observational evidence links ultraprocessed food with heart disease, cancer, death

Stem Cell Infusion Cut Fractures; Testosterone for Menopause; BMD and Cognition

— News and commentary from the endocrinology world

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Latest News

Health news and commentary gathered by MedPage Today staff

— Approval marks the second once-weekly basal insulin for this population

— Analysis found increased pneumonia, heart failure, and bleeding risks

Agency's letter flagged issues with copycat manufacturing and sterility

— Mounting observational evidence links ultraprocessed food with heart disease, cancer, death

— News and commentary from the endocrinology world

News All Time

About a Quarter of Those Who Stop Wegovy Start Again

Real-world Danish data showed steady discontinuation among first-time users

GLP-1 Drugs Tied to Gallbladder and Biliary Risks in Youth

Real-world study identifies safety signal in young people with overweight or obesity

Mounjaro's Label Expands; Type 1 Diabetes on the Rise; Testosterone and Afib

News and commentary from the endocrinology world

High Fertility Costs Push Americans Abroad for IVF Treatment

Infertility affects nearly 7 million in the U.S.

Pesticide Found in Supplement; Brain-Eating Amoeba Kills Teen; B12 and Birth Defects

Health news and commentary gathered by MedPage Today staff

ADA Says Booted Meeting Attendees Violated Code of Conduct

Expelled researchers unhappy with conclusion of organization's review

Off-Label GLP-1 Use Skyrockets in Young Kids

Weight-loss formulations are only approved for kids 12 years and older

Endometriosis Can Elude Diagnosis for Years. What to Know About New Ways to Find It.

New tests available abroad are raising hope among doctors and patients

New GLP-1 Hair Loss Insights; Wegovy in Kids; Are Fitness Trackers Lying to Users?

News and commentary from the endocrinology world

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

TIMBERLINE study shows good safety and sweat chloride reductions with triple combo CFTR modulator

Menopausal Hormone Therapy May Ease Severe Mood Symptoms

Therapy also associated with better sleep scores in non-controlled study

The CDC Division I Spent 15 Years Building Is in Peril

Cuts to the Division of Nutrition, Physical Activity, and Obesity will not make America healthy

The Market Forces Quietly Adding Thousands to Patient Bills

A look at a shifting industry

Preserving Muscle During GLP-1 Weight Loss

Experts advise tracking body composition, boosting protein, and resistance training

Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility

News and commentary from the endocrinology world

ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space

MedPage Today reporters offer further insights into recently covered topics

Recommended News For You

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

Significant differences in breast cancer care still exist, but surgeons can change.

Lesser-known lobular breast cancer on the rise in U.S. women

Which Risk Model Better Identifies High-Risk Smoldering MM?

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

AI tool identifies women at high risk of interval breast cancer

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

Recommended Articles For You

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer 

Care Coordination in Chronic Anemia: Mechanisms, Clinical Implications, and Emerging Strategies 

Hemophilia: Pathophysiology, Genetics, and Treatment Advances 

Clinical Frameworks in Hematology for Better Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.

2.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

3.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?

4.

fresh E. Coli Outbreak: ECMO Redefining Death and Bringing Universal Blood One Step Nearer.

5.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

1.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

2.

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders

3.

The New Era of Oncology: Key Updates and Clinical Insights

4.

How HLH is Revolutionizing Healthcare

5.

Digital Cancer Caregiver Coordination Platforms: Advances, Clinical Impact, and Future Directions

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

How Advances in Cancer Research Are Improving Treatment Options

2.

From Guidelines to Practice: Hematology

3.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

4.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

5.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot